Rockville, MD, United States of America

Brian Howie

This inventor holds 1 USPTO granted patent. Top assignee: Regenxbio Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brian Howie. Retrieved from https://idiyas.com/inventor/brian-howie

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Brian Howie and His Work in Adeno-Associated Virus Analysis.

Introduction

Brian Howie is an inventor based in Rockville, Maryland, whose patent work concerns methods for analyzing adeno-associated virus (AAV) particles. His disclosed invention applies spectrophotometry to estimate genome copies and assess the proportion of full and empty AAV particles. The provided information lists one patent associated with him and identifies Regenxbio Inc. as his company.

Latest Patents

Howie’s listed patent is “Systems and Methods of Spectrophotometry for the Determination of Genome Content, Capsid Content and Full/Empty Ratios of Adeno-Associated Virus Particles.” The disclosure describes using spectrophotometry to estimate genome copies and determine full-to-empty ratios in AAV particles. These measurements address key characteristics used in evaluating viral-vector preparations.

Career Highlights

The available information highlights Howie’s contribution as an inventor in the field of AAV analysis. His listed patent focuses on applying spectrophotometric methods to characterize genome and capsid content.

Collaborations

The provided data names Zhuchun Wu and Keith Webber as Howie’s coworkers. Their inclusion reflects a professional connection, though the available information does not specify their roles in the patent.

Conclusion

Brian Howie’s listed invention applies spectrophotometry to the analysis of AAV genome content and full-to-empty particle ratios, connecting his patent work with Regenxbio Inc. and the named colleagues.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…